Earnings Ahead

GILD - Gilead Sciences Inc

76.42 0.3 0.39

Gilead Sciences Inc

Gilead Sciences Inc

About

Profile

At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world.


Headquarters

Foster City, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

GILD



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Gilead Sciences Non-GAAP EPS of $1.72 misses by $0.04, revenue of $7.12B beats by $20M
  • Gilead set to roll out Q4 results post-market Tuesday
  • Gilead Sciences stock traded in the red for seventh straight session
  • Earnings week ahead: Alibaba, PepsiCo, Disney, Palantir, McDonalds, Ford and more
  • Arcus Biosciences: Did Gilead Sciences overpay for its latest investment?
  • Gilead gets FDA okay for faster Yescarta production process
  • Arcus shares extend gains amid mixed reactions on Gilead stake purchase
  • Gilead invests $320M in Arcus, expands stake to 33%
  • Big Pharma earnings season in spotlight amid positive sentiment
  • PBMs ramp up lobbying efforts amid growing public scrutiny
  • Gilead stands behind benefits of its CAR-T therapies
  • CAR-T therapies to get boxed warning on blood cancer risk
  • Gilead in selloff after late-stage setback for Trodelvy
  • Biggest stock movers today: Boeing, NuStar Energy, Archer-Daniels-Midland, and more
  • Gilead stock drops as Trodelvy fails Phase 3 lung cancer trial
  • Eli Lilly’s Jaypirca to lead BTK inhibitor market for leukemia
  • Arcus posts early-stage data for Gilead-partnered cancer therapy
  • First RSV shots, groundbreaking gene therapy among 2024 drugs to watch
  • Health stocks to watch this earnings season as sector poised for resurgence
  • Gilead must face negligence claims over HIV drug development, court says
Date Price Open High Low Vol Change
Jan 29 95.59 94.4
95.93
94.08
5.6M 1.85%
Jan 28 93.85 95
96.7
93.81
7.4M -1.57%
Jan 27 95.35 93.1
95.84
93.1
7.9M 2.45%
Jan 24 93.07 92.36
94
92.26
5.4M 0.16%
Jan 23 92.92 93.03
93.29
92.21
4.1M -0.13%
 
Jan 22 93.04 92.63
93.31
91.84
7.3M 0.09%
Jan 21 92.96 92.06
93.9
92.06
10.5M 1.22%
Jan 17 91.84 92.01
92.8
91.68
6.9M 0.21%
Jan 16 91.65 92.26
93.07
90.82
9.0M -0.79%
Jan 15 92.38 91.35
92.66
91.04
8.1M 1.52%
Jan 14 91 90.59
91.48
89.83
7.4M 1.18%
Jan 13 89.94 90.3
90.37
89.02
6.5M 0.07%
Jan 10 89.88 90.19
91.43
88.57
7.9M 0.83%
Jan 8 89.14 90.68
90.68
89
8.1M -1.64%
Jan 7 90.63 90.89
91.51
90.51
5.8M -0.66%
Jan 6 91.23 90.75
91.53
90.32
6.8M -0.2%
Jan 3 91.41 92.19
92.34
91.31
4.3M -0.51%
Jan 2 91.88 92.62
92.83
91.4
3.5M -0.53%
Dec 31, 2024 92.37 92.59
92.98
91.78
3.5M 0.39%
Dec 30, 2024 92.01 93.93
94
91.72
3.6M -2.23%
Dec 27, 2024 94.11 93.43
94.38
93.43
3.3M -0.32%
Dec 26, 2024 94.41 93.17
94.55
92.97
2.9M 0.49%
Dec 24, 2024 93.95 93
94.05
92.1
2.1M 0.59%
Dec 23, 2024 93.4 92.62
93.52
91.79
4.8M 0.90%
Dec 20, 2024 92.57 90.92
93.29
90.71
22.5M 1.62%
Dec 19, 2024 91.09 90.4
91.48
90.27
8.9M 0.44%
Dec 18, 2024 90.69 92.72
93.5
90.59
6.6M -2.27%
Dec 17, 2024 92.8 91.88
93.59
91.88
6.1M 0.81%
Dec 16, 2024 92.05 91.96
93.26
91.9
7.1M 0.21%
Dec 13, 2024 91.86 91.66
92.11
89.15
7.5M -0.56%
Dec 12, 2024 92.38 92.46
93.22
91.44
5.8M 0%
Dec 11, 2024 92.38 92.4
94.65
91.94
7.5M 0.04%
Dec 10, 2024 92.34 91.35
92.95
90.64
6.7M 1.93%
Dec 9, 2024 90.59 91.86
92.15
90.5
7.4M -1.67%
Dec 6, 2024 92.13 93.5
94.22
92.03
4.5M -1.35%
Dec 5, 2024 93.39 91.6
94.27
91.6
12.4M 1.97%
Dec 4, 2024 91.59 92.59
92.6
89.86
9.1M -0.97%
Dec 3, 2024 92.49 93.81
94.39
92.46
5.5M -1.63%
Dec 2, 2024 94.02 92.53
94.36
92.49
5.0M 1.56%
Nov 29, 2024 92.58 92.84
93.16
92.33
3.9M 0.18%
Nov 27, 2024 92.41 91.44
92.89
91.44
5.5M 1.16%
Nov 26, 2024 91.35 90.34
91.68
89.63
4.4M 0.95%
Nov 25, 2024 90.49 90.75
91.36
89.5
10.8M 0.33%
Nov 22, 2024 90.19 89.81
90.49
89.27
4.5M 0.48%
Nov 21, 2024 89.76 89.07
89.94
88.07
4.1M 1.27%
Nov 20, 2024 88.63 88.11
89.08
87.77
4.8M 1%
Nov 19, 2024 87.75 87.63
88.6
86.08
8.2M -0.8%
Nov 18, 2024 88.46 88.39
89.04
87.63
9.1M 0.07%
Nov 15, 2024 88.4 91.71
91.99
88.21
11.5M -4.03%
Nov 14, 2024 92.11 92.31
92.66
91.29
8.2M -0.56%
Nov 13, 2024 92.63 94.13
94.21
91.63
11.1M -1.82%
Nov 12, 2024 94.35 96.35
96.84
94.22
9.3M -2.76%
Nov 11, 2024 97.03 96.4
98.9
96.3
7.1M 0.48%
Nov 8, 2024 96.57 96.05
97.32
94.91
7.5M -1.36%
Nov 7, 2024 97.9 94
98.32
93.51
14.4M 6.77%
Nov 6, 2024 91.69 91
91.98
90.5
8.8M 1.63%
Nov 5, 2024 90.22 89.64
90.39
89.01
4.0M 0.42%
Nov 4, 2024 89.84 89.49
90.71
89.37
6.1M 0.37%
Nov 1, 2024 89.51 88.31
89.57
88.19
6.5M 0.78%
Oct 31, 2024 88.82 87.94
89.28
87.74
5.9M 0%